Results for tag: "Plaque Psoriasis Drug"

Plaque Psoriasis is a chronic, inflammatory skin disorder that affects millions of people worldwide. It is characterized by red, scaly patches on the skin, which can be itchy and painful. Treatment for plaque psoriasis typically involves the use of immune-modulating drugs, such as biologics, which target specific pathways in the immune system. These drugs are used to reduce inflammation and slow the progression of the disease. Other treatments, such as topical creams and light therapy, may also be used in combination with immune-modulating drugs. The Plaque Psoriasis Drug market is a rapidly growing segment of the Immune Disorders Drugs market. It is driven by the increasing prevalence of psoriasis, as well as the development of new and more effective treatments. The market is highly competitive, with a number of major pharmaceutical companies offering a range of treatments. Some of the major companies in the Plaque Psoriasis Drug market include AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, and UCB. Show Less Read more